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Summary
Objective: We conducted a proteome analysis of human articular chondrocytes, in order to identify proteins differentially expressed in chon-
drocytes during the progression of osteoarthritis (OA) and to characterize the phosphorylation status of these proteins.
Methods: The proteins of 20 samples of human chondrocytes obtained from the cartilage of human knees (six from healthy cartilage (NoNo),
seven from visually intact zones (NoOA) and seven from visually damaged zones (OAOA) of OA cartilage from the same knee joint) were
sequentially extracted and subjected to two-dimensional gel electrophoresis (2-DE). Protein expression patterns were subjected to statistical
analysis and protein spots of interest were identiﬁed by electrospray ionization tandem mass spectrometry.
Results: We identiﬁed several protein spots, showing a differential expression between the sample groups. Cleaved vimentin was upregulated
in OAOA samples, this was conﬁrmed by 1-DE and Western blot. The possible impact of vimentin cleavage on the chondrocyte’s cytoskeleton
was illustrated by confocal microscopy analysis, which revealed a distorted vimentin organization in OA chondrocytes. In contrast, F-actin
staining did not reveal differences.
Conclusion: All together, this study revealed substantial alterations in the vimentin cytoskeleton in OA-affected human articular chondrocytes.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common disabling human
condition in the Western world, which ultimately results in
degeneration of the articular cartilage. Now, it is clear that
the chondrocyte plays a critical role in cartilage degenera-
tion. In the recent years, several studies were performed
to reveal changes in the cellular phenotype during OA car-
tilage degeneration. Some of them investigated the expres-
sion of single genes by reverse transcriptase-polymerase
chain reaction (RT-PCR), Western blotting or immunocyto-
and histochemistry1e5. Other studies investigated a broader
set of genes using cDNA-array technology6 or antibody mi-
croarrays7. In a recent study, the gene expression proﬁles
of normal cartilage and intact and damaged regions of OA
cartilage were compared using cDNA arrays8. Despite
these studies, the knowledge about the molecular mecha-
nism of cartilage destruction in OA can still be improved.
The introduction of proteomics techniques enables the
large-scale identiﬁcation of proteins and the large-scale
comparison of protein levels in a wide range of diseases.
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163elucidate the human proteome. Nevertheless, two-dimen-
sional gel electrophoresis (2-DE) is the most widely applied
technique to screen for differentially expressed proteins.
2-DE can still be considered as the most comprehensive
analysis method for detecting a wide variety of post-transla-
tional modiﬁcations (PTMs), for example phosphorylation
and protein cleavage. In such an approach, proteins are sep-
arated based on the isoelectric point (pI) in the ﬁrst dimen-
sion and on the molecular weight (Mw) in the second
dimension. After spot visualization, spot intensities can be
compared and spots of interest can be identiﬁed by mass
spectrometry (MS). Recently, some studies describing the
proteome of chondrocytes9 or cartilage10 have been pub-
lished. However, no comparison was made between healthy
and OA-affected chondrocytes. Using a 2-DE approach,
Hermansson et al.11 investigated the proteins secreted by
normal and OA chondrocytes. This study revealed several
differentially secreted proteins by OA chondrocytes, but in-
tracellular proteins were not investigated. To gain new in-
sights in the molecular control mechanisms, involved in
the development of OA, we analyzed the proteome of cul-
tured chondrocytes and their cell-associated matrix (CAM)
from healthy donors and OA patients. Since chondrocytes
are the only cells in cartilage, which regulate the normal
anabolism and catabolism of the cartilage matrix, an alter-
ation in the protein expression pattern of these cells can in-
ﬂuence the normal matrix homeostasis. The identiﬁcation of
differentially expressed proteins can help us to identify new
players in the progression of OA, to better understand the
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peutic targets in this disease.
Aigner et al.12 reviewed studies of functional genomics of
OA and emphasized the importance of such gene expres-
sion analysis to evaluate disease hypotheses and under-
stand complex diseases such as OA. However, mRNA
levels often do not correlate with protein levels and phe-
nomena such as PTMs and protein processing cannot be
discovered using such transcriptome studies. A proteomic
approach, which identiﬁes PTMs, differentially expressed
proteins or differentially processed proteins is a valuable
complement to gene expression studies.
Using 2-DE, sequential staining procedures and MS, we
were able to identify isoforms of proteins showing an altered
abundance in chondrocytes isolated from healthy cartilage
versus visually intact or degenerated zones of OA cartilage.
The combination of these data with Western blot analysis
and confocal microsocopy revealed a distorted vimentin
organization in OA chondrocytes.Materials and methodsSUBJECTSHealthy articular cartilage (NoNo) was obtained from 12
donors (nine males, three females; age: 18e72 years) within
24 h post-mortem. All donors had died as a result of trauma
or a brief illness and none of them had been receiving corti-
costeroids or cytostatic drugs. OA-affected cartilage was ob-
tained from14 patients (sixmales, eight females; age: 47e79
years) within 24 h from total knee arthroplasty. The cartilage
from each of these patients was separated in visually intact
cartilage (NoOA) and cartilage showing OA lesions
(OAOA). Figure 1 shows an image of a sample of NoOA
and OAOA cartilage from the same patient, stained with
Indian ink, allowing ﬁbrillated cartilage to be recognized13.
The study was approved by the local Ethics Committee.ISOLATION AND CULTURE OF CHONDROCYTESHuman articular chondrocytes were isolated as previously
described14. The cartilage was diced into small fragments
and chondrocytes were isolated by sequential enzymatic
digestion [hyaluronidase, pronase, collagenase (Sigmae
Aldrich, Steinheim, Germany)] as described in detailFig. 1. Image of articular cartilage stained with Indian ink. Both sam-
ples were isolated from the femur condyle from the same patient.
On the upper slice (OAOA) the ﬁbrillated surface is clearly visible.
The lower slice (NoOA) shows a smooth, non-ﬁbrillated surface.elsewhere14. Trypan blue exclusion revealed that >95%
of the cells were viable after isolation.
Chondrocyte cultures in alginate beads were prepared as
described by Guo et al.15, with some modiﬁcations16.
Brieﬂy, chondrocytes suspended in one volume of double-
concentrated Hanks’ balanced salt solution (HBSS; Gibco,
Grand Island, NY, USA) without calcium and magnesium
were carefully mixed with an equal volume of 2% alginate.
The ﬁnal chondrocyte concentration was 5 106 cells/ml.
The chondrocyteealginate suspension was slowly dripped
through a 23-gauge needle into a 102 mM solution of cal-
cium chloride and the beads were allowed to polymerize
for 10 min at room temperature. Calcium chloride was re-
moved and the beads were washed three times with 0.9%
sodium chloride.
The beads were maintained in a six-well plate (20 beads/
well; 50.000 chondroctyes/bead) containing Dulbecco’s
modiﬁed Eagle medium (DMEM) (Gibco) with 10% fetal
calf serum, antibiotics and antimycotics (Gibco) and
50 mg/ml ascorbate in an incubator at 37C and in 5%
CO2. Medium was replaced three times a week for 10 days.2-D POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE)After the culture period, the medium was aspirated and
the alginate beads were washed and dissolved by incuba-
tion in 55 mM tri-sodium citrate dihydrate pH 6.8, at room
temperature. The resulting suspension was centrifuged at
1500 rpm for 10 min to separate cells with their CAM17
from the constituents of the interterritorial matrix5. The re-
sulting cell pellet was washed three times with PBS. After
washing and centrifugation, the chondrocytes were resus-
pended in Reagent 1 (40 mM Tris) from the ReadyPrep
Sequential Extraction Kit (Bio-Rad, Hercules, CA, USA),
containing protease inhibitors (Roche Diagnostics, Man-
nheim, Germany), a phosphatase inhibitor-cocktail
(SigmaeAldrich, Steinheim, Germany) and endonucleases
(SigmaeAldrich). Cells were lysed and the proteins were
extracted using the ReadyPrep Sequential Extraction Kit
(Bio-Rad) according to the manufacturer’s protocol with
the exception that the second and third fractions were com-
bined. This resulted in a soluble and hydrophobic protein
fraction. Using this approach, an increase in the total num-
ber of protein spots is detected and a more simpliﬁed pro-
tein pattern is achieved18. The soluble fraction is
considered to be the representative of the cytosolic proteins
and the hydrophobic fraction of the membrane-associated
proteins.
2-DE was performed according to Tilleman et al.19 with
some minor modiﬁcations. The soluble fraction was de-
salted using ice-cold acetone precipitation. Proteins were
dissolved in 300 ml of rehydration solution containing
7 Murea, 2 M thiourea, 4% 3-[(3-cholamidopropyl)dimethy-
lamonio]-1-propanesulfonate (CHAPS), 0.2% carrier am-
pholyte solution and 12 ml/ml Destreak Reagent
(Amersham Biosciences, Uppsala, Sweden). The hydro-
phobic fraction was diluted with an appropriate volume of
the above rehydration buffer to achieve a ﬁnal volume
of 300 ml. Samples were applied to 17 cm non-linear pH
3e10 strips (Bio-Rad) and rehydrated overnight. Isoelectric
focusing was performed for 100 kVh on the Protean iso-
electrical-focusing (IEF) cell (Bio-Rad). After focusing, pro-
teins were reduced and alkylated by incubating the strips
for 15 min in 15 ml of equilibration buffer (6 M urea, 2%
(w/v) sodium-dodecyl-sulfate (SDS), 50 mM TrisHCl, and
30% glycerol) containing 2% dithiothreitol (DTT) (w/v) for
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respectively.
The strips were transferred onto vertical 12% (soluble
fraction) and 10% (hydrophobic fraction) self-cast gels and
ﬁxed in place with 0.5% agarose. The second-dimensional
gel electrophoresis was performed on a vertical Protean II
xi Multi Cell (Bio-Rad) for 30 min at 16 mA/gel followed by
32 mA/gel for approximately 4.5 h at 10C.
The gels were sequentially stained with Pro-Q Diamond
(Molecular Probes, Eugene, Oregon) according to the man-
ufacturer’s protocol. Peppermint Stick Phosphoprotein Mo-
lecular Weight Standards (Molecular Probes) were run
beside the IEF-strip as positive and negative control for
the Pro-Q Diamond stain. The image was acquired using
a VersaDoc-imaging system (Bio-Rad) with ultraviolet
(UV) excitation and a 520 nm longpass emission ﬁlter. After
detection of the phospho-image, gels were stained with Sy-
pro Ruby (Bio-Rad) according to the manufacturer’s proto-
col. Proteins were detected using a VersaDoc with UV
excitation and a 520 nm longpass emission ﬁlter.
Sypro Ruby stained images were processed and analyzed
using PDQuest software Version 7.10 (Bio-Rad). Spots were
detected using the spot detectionwizard, backgroundwas re-
moved by applying the ﬂoater background. Gels were
matched to each other creating a match set standard image,
which contains match information from all the individual gels.
Spot intensities were normalized for total quantity in
valid spots, in order to correct for small pipetting errors, minor
staining differences, etc. This normalization strategy implies
that the raw quantity of each spot is divided by the total
quantity of all the spots in that gel that have been included
in the master. Spots were considered as ‘signiﬁcant differen-
tially expressed’ if spot intensities were signiﬁcantly
(P-value< 0.05) different between the groups NoNo and
NoOA or OAOA (ManneWhitney U test). The ‘NoOA’ and
‘OAOA’groupswerecomparedusingWilcoxon’spaired-sample
test; P-values< 0.05 were considered statistically signiﬁcant.SAMPLE PREPARATION FOR MS ANALYSIS2-D gel spots of interest were excised and transferred to
micro-centrifuge tubes. The gel spots were washed twice
(10 min/wash) with 200 ml of 25 mM ammonium bicarbon-
ate/50% acetonitrile, dehydrated using acetonitrile until
spots turn opaque and dried until complete dryness in a vac-
uum centrifuge. Proteins were digested with sequencing
grade trypsin (Promega, Madison, WI, USA, 10 ng/ml in
25 mM ammonium bicarbonate) overnight at 37C. Pep-
tides were extracted twice using, 75 ml of a 50% acetoni-
trile/5% triﬂuoroacetic acid solution, extracts of the same
spot were pooled and dried in a vacuum centrifuge.MS AND DATABASE ANALYSISPeptides were resuspended using 0.1% formic acid. For
electrospray-ionization quadrupole time-of-ﬂight (ESI Qq-
Tof) analysis, the resuspended peptides were injected on
a Famos autosampler (LC Packings, Sunnyvale, CA,
USA) and concentrated on a trap column (PepMap, LC
Packings) in buffer A (0.1% formic acid in water). Peptides
were separated on a C18 PepMap column (LC Packings)
by a 45 min linear gradient from 6% to 100% buffer B
(80% acetonitrile and 0.1% formic acid in water). The ﬂow
rate was 150 nl/min (Ultimate pump, LC Packings).
ESI Qq-Tof analysis was performed on a Q-Tof I or a
Q-Tof Ultima mass spectrometer (Waters, Milford, USA),which was coupled to the LC-system via a nano-LC inlet.
The instrument was calibrated using fragment ions gener-
ated from tandem mass-spectrometry (MS/MS) spectra of
Glu-ﬁbrinopeptide B (SigmaeAldrich).
Data processing and database searches against the
Swiss-Prot database were performed using the Protein
Lynx Global Server V.2.0 search engine (Waters) and via
Mascot (http://www.matrixscience.com) or GPM X!3 algo-
rithm (www.thegpm.org) after processing the MS/MS spec-
tra using Mass Lynx v4.0. For an extended description of
the protein identiﬁcation parameters and the validation of
the identiﬁcations, see Supplementary data.WESTERN BLOT ANALYSISEqual amounts (30 mg as determined by 2-D Quant kit,
GE Healthcare, Fairﬁeld, USA) of soluble fractions of 12
patients (four NoNo, four NoOA and four OAOA) were
loaded on 10% SDS-PAGE gel. Equal loading was veri-
ﬁed by Ponceau S staining (data not shown). MagicMark
(Invitrogen, Paisley, UK) protein standards were run as
Mw markers. 2-D gels were run as described above (sol-
uble fraction from two NoNo samples and two OAOA
samples), except that the sample was applied to immobi-
lized pH gradient (IPG)-zoom strips (pH 4e7, Bio-Rad)
and, after equilibration, strips were transferred to precast
10% SDS-PAGE Criterion gels (Bio-Rad). Strips were fo-
cused for 35 kVh and SDS-PAGE was performed at
200 V for approximately 1 h. For one OAOA sample,
a second gel was run in parallel and Sypro Ruby stained,
to allow spot picking and MS analysis, as described
above. Following 1-DE and 2-DE, proteins were trans-
ferred to nitrocellulose membranes (Bio-Rad). The result-
ing membranes were immunoblotted with anti-Vimentin
MAb clone V9 (SigmaeAldrich), followed by anti-mouse
horseradish peroxidase (HRP)-conjugated Ab (Pierce,
Rockford, IL, USA) and enhanced chemiluminescence
(ECL) chemiluminescence (Pierce). Chemiluminescence
images were recorded using the VersaDoc-imaging sys-
tem (Bio-Rad). Densitometric analysis of the images
was performed by Quantity One Software v 4.4.0 (Bio-
Rad).IMMUNOFLUORESCENCE MICROSCOPYChondrocytes of cartilage samples of two additional healthy
patients (NoNo)and threeadditionalOApatientswere isolated
and cultured as describedabove. In one of theOApatients, no
visually intact cartilage was present. Chondrocytes cultivated
in alginate beads for 10 days were washed in phosphate-buff-
ered saline (PBS) for 5 min. The medium used during sample
processing was a modiﬁed HBSS (mHBSS) as described by
Langelier et al.20 Chondrocytes were ﬁxed in the alginate
beads using 4% para-formaldehyde (SigmaeAldrich) for
15 min. Fixation was stopped by three washes in 100 mM
glycine. Alginate beads were smeared on poly-l-lysine coated
glass slides. Specimens were permeabilized using Triton
X-100 (SigmaeAldrich) 0.5%. Samples were washed
and blocked using 5% normal goat serum (NGS) for 1 h
and were incubated overnight at 4C with primary mouse
anti-vimentin clone V9 (SigmaeAldrich) in 1% NGS in
mHBSS. After three washes, they were incubated with
anti-mouse Alexa Fluor 488-conjugated secondary antibody
(Molecular Probes) in 1% NGS, followed by phalloidin-
tetramethyl rhodamine iso-thiocyanate (TRITC)
(SigmaeAldrich) staining for 1 h. Sampleswerewashed three
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nuclear stain (Molecular Probes). Finally, glass slides were
washed four times in mHBSS. The slides were mounted on
a coverslip and samples were examined with confocal laser
scanning microscopy (Bio-Rad MRC1024). At least 20, ran-
domly selected, individual chondrocytes of each sample
were imaged.ResultsCOMPARATIVE PROTEOME ANALYSIS OF NORMAL
AND OA CHONDROCYTESFig. 3. Match set’s standard image of 2-D separated proteins of the
hydrophobic fraction (derived from OAOA sample). Numbered
spots are identiﬁed by MS.We initiated this study by performing 2-DE, for both the
soluble and hydrophobic fractions, on 20 samples [six
healthy (NoNo), seven visually intact zones of cartilage
from OA patients (NoOA), and seven visually damaged
zones of OA cartilage (OAOA)]. Extraction of the proteome
from chondrocytes yielded an average cytosolic protein
concentration of 2.39 0.60 mg/ml and an average hydro-
phobic protein concentration of 1.94 0.48 mg/ml. Gels
were stained, scanned and digitized as described above.
The match set’s standard images are shown in Figs. 2
and 3. In the samples of the soluble fraction 1301 141
spots could be detected on each gel. In the hydrophobic
fraction 1212 96 spots (Sypro Ruby stain) could be de-
tected. Spots which showed a signiﬁcant (P< 0.05) differ-
ent intensity between NoNo vs NoOA or OAOA samples
in ManneWhitney U test were considered as protein spots
with a signiﬁcant altered expression. The identiﬁed proteins
are shown in Tables I and II. As NoOA and OAOA chondro-
cytes are isolated from the same knee joint, the correspond-
ing spot intensities were compared using a Wilcoxon
paired-sample test. This revealed 17 identiﬁed proteins,
which are differentially (P< 0.05) expressed (Table III).
Among the identiﬁed spots, several proteins are known to
be involved in metabolic pathways [transaldolase, 6-phos-
phogluconolactonase, alpha-enolase and triose-phosphate
isomerase and adenosine triphosphate (ATP)-synthase
(a-subunit)]. Furthermore proteins related to apoptoticFig. 2. Match set’s standard image of 2-D separated proteins of the
soluble fraction (derived from OAOA sample). Numbered spots are
identiﬁed by MS.pathways (voltage-dependent anion-selective channel
(VDAC)-proteins and Annexins) and oxidative stress [per-
oxiredoxin 6, Cu/Zn superoxide dismutase (Cu/ZnSOD),
and Mn superoxide dismutase (MnSOD)] were identiﬁed.
Of special interest was the identiﬁcation of two spots,
both upregulated in OAOA, as vimentin (Fig. 4). Both spots
were located in the gel below the expected Mw of native vi-
mentin (Fig. 2), suggesting a more pronounced vimentin
cleavage in OAOA.SEVERAL DIFFERENTIALLY EXPRESSED PROTEINS WERE
SHOWN TO BE PHOSPHORYLATED, USING SPECIFIC IN-GEL
STAINING OF PHOSPHOPROTEINSWe next evaluated the phosphorylation status of differen-
tially expressed proteins. Therefore, samples were sequen-
tially stained with Pro-Q Diamond and Sypro Ruby. The
Peppermint Stick Phosphoprotein Molecular Weight Stan-
dards showed the expected staining pattern for phosphory-
lated proteins, indicating the selectivity of the Pro-Q
Diamond staining procedure (results not shown). In the
samples of the soluble fraction 122 15 spots could be de-
tected on each gel, whereas in the hydrophobic fraction
96 17 spots (ProQ-Diamond stain) could be detected.
Spots showing a differential expression pattern in the com-
parative proteome analysis and which stained positive
with Pro-Q Diamond are indicated as phosphoproteins in
Tables IeIII. Among these identiﬁed phosphorylated pro-
teins, coﬁlin-1 is of special interest. Moreover, a known
phosphorylation site at Ser-3 could be identiﬁed by MS
(Supplementary data, Fig. 1). Coﬁlin is a key regulator of ac-
tin organization as this protein is involved in severing and
depolymerization of actin ﬁlaments (reviewed by DesMarais
et al.21). As the activity of coﬁlin is inhibited by phosphory-
lation22, the detected upregulation of this protein in OAOA
chondrocytes will not necessarily result in a higher activity
of this protein. Whether this had a biological impact on actin
ﬁlaments was further investigated by immunoﬂuorescence
(see below).
Table I
Identified protein spots, differentially expressed (P< 0.05) between
NoNo and NoOA samples. The Swiss-Prot accession number is
mentioned between brackets. Standard Spot number (SSP) indi-
cates the spot number (numbers followed by H refer to spots
from hydrophobic fraction). ‘Phosphorylation’ indicates if spot was
stained using Pro-Q Diamond. ‘ESI MS/MS’ indicates the number
of peptide sequences obtained from ESI Q-ToF used for identifica-
tion. ‘Ratio’ is the ratio of the average normalized spot intensity of
the NoOA to NoNo group
SSP Protein Phosphorylation ESI
MS/MS
Ratio
A. Protein spots showing a higher expression in NoOA vs NoNo
0819 Glucosidase II beta
subunit precursor
(P14314)
Yes 5 4.77
2505 Mannose-6-phosphate
receptor binding
protein 1 (O60664)
4 2.98
3501 H Stomatin-like protein
2 (Q9UJZ1)
3 2.59
3714 Heat shock protein
70 kDa protein 1
(P08107)
2 2.28
5602 H Protein disulﬁde
isomerase A3
(P30101)
2 2.00
6308 Annexin A1 (P04083) 5 4.95
6515 Alpha enolase
(P06733)
2 1.65
7211 H Superoxide dismutase
Mn (P04179)
3 2.08
8609 H ATP-synthase
a-chain (P25705)
6 29.37
B. Protein spots showing a lower expression in NoOA vs NoNo
1003 Divalent cation tolerant
protein CUTA (O60888)
2 0.55
1103 Calcyphosine (Q13938) Yes 3 0.44
2112 Superoxide dismutase
Cu/Zn (P00441)
1 0.24
4104 DJ-1 protein (Q99497) 2 0.49
4218 Peroxiredoxin 6
(P30041)
6 0.59
7006 Cystatin B (P04080) 2 0.45
7014 Neddylin (Q15843) 2 0.49
Table II
Identified protein spots, differentially expressed (P< 0.05) between
NoNo and OAOA samples. The Swiss-Prot accession number is
mentioned between brackets. ‘SSP’ indicates the spot number
(numbers followed by H refer to spots from hydrophobic fraction).
‘Phosphorylation’ indicates if spot was stained using Pro-Q Dia-
mond. ‘ESI MS/MS’ indicates the number of peptide sequences ob-
tained from ESI Q-ToF used for identification. ‘Ratio’ is the ratio of
the average normalized spot intensity of the OAOA to NoNo group
SSP Protein Phosphorylation ESI
MS/MS
Ratio
A. Protein spots showing a higher expression in OAOA vs NoNo
0819 Glucosidase II beta
subunit precursor
(P14314)
Yes 5 2.47
1404 Vimentin (P08670) 16 2.50
1437 Vimentin (P08670) Yes 7 3.03
2002 Eukaryotic translation
initiation factor 5A
(P63241)
1 4.32
3213 Beta-hexosaminidase
beta chain (P07686)
2 3.99
3501 H Stomatin-like protein
2 (Q9UJZ1)
3 1.81
3705 H Heat shock cognate
71 kDa protein
(P11142)
7 1.62
3714 Heat shock protein
70 kDa protein 1
(P08107)
2 2.52
5602 H Protein disulﬁde
isomerase A3
(P30101)
2 2.7
6306 H Voltage-dependent
anion-selective channel
protein 2 (P45880)
2 1.86
6308 Annexin A1 (P04083) 5 5.23
6503 Alpha enolase
(P06733)
3 1.5
6515 Alpha enolase
(P06733)
2 1.75
6712 H Lamin A/C (P02545) 3 2.97
7206 H Superoxide dismutase
Mn (P04179)
Yes 3 1.76
7211 H Superoxide dismutase
Mn (P04179)
3 2.91
8212 3-Hydroxyacyl-CoA de-
hydrogenase type II
(Q99714)
2 13.83
8302 H Voltage-dependent an- 3 1.65
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ion-selective channel
protein 1 (P21796)
8609 H ATP-synthase
a-chain (P25705)
6 52.97
B. Protein spots showing a lower expression in OAOA vs NoNo
1003 Divalent cation tolerant
protein CUTA
(O60888)
2 0.65
1103 Calcyphosine (Q13938) Yes 3 0.51
2112 Superoxide dismutase
Cu/Zn (P00441)
1 0.42
3104 Superoxide dismutase
Cu/Zn (P00441)
2 0.37
4104 DJ-1 protein (Q99497) 2 0.57
4218 Peroxiredoxin 6
(P30041)
6 0.38
5005 Fatty acid-binding pro-
tein (P05413)
2 0.33
7006 Cystatin B (P04080) 2 0.55
7014 Neddylin (Q15843) 2 0.55As the data of the differential proteome analysis point to
vimentin cleavage, vimentin and its cleavage products
were investigated by 1-DE and Western blotting, using
a monoclonal antibody directed against a C-terminal amino
acid sequence of human vimentin. 1-D Western blots
clearly indicate the higher abundance of a band near
53 kDa, the Mw of native vimentin, in NoNo and NoOA sam-
ples compared to OAOA samples (Fig. 5). Moreover, a lower
Mw band (near 43 kDa) of vimentin was found to be more
intense in three OAOA samples. A less intense staining of
vimentin was observed in hydrophobic fractions, which
showed less explicit differences between NoNo and
NoOA/OAOA samples in the 53 kDa region (Supplementary
data, Fig. 2).
These ﬁndings conﬁrmed the difference between NoNo
and OAOA samples observed by 2-DE. In addition, differ-
ences between the NoOAandOAOA groupswere observed.
It should be noted however, that in the 2-DE analysis differ-
ences in vimentin spot intensities between NoOA andOAOA
Table III
Identified protein spots, differentially expressed (P< 0.05) between
NoOA and OAOA samples. The Swiss-Prot accession number is
mentioned between brackets. ‘SSP’ indicates the spot number
(numbers followed by H refer to spots from hydrophobic fraction).
‘Phosphorylation’ indicates if spot was stained using Pro-Q Dia-
mond. ‘ESI MS/MS’ indicates the number of peptide sequences ob-
tained from ESI Q-ToF used for identification. ‘Ratio’ is the ratio of
the average normalized spot intensity of the OAOA to NoOA group
SSP Protein Phosphorylation ESI
MS/MS
Ratio
A. Protein spots showing a higher expression in OAOA vs NoOA
3012 S100 calcium-binding
protein A4 (P26447)
2 2.11
4205 6-Phosphogluconolactonase
(O95336)
2 1.84
5116 Coﬁlin-1 (P23528) Yes 2 1.45
5207 Protein-L-isoaspartate
(D-aspartate)
O-methyltransferase
(P22061)
3 1.62
5214 Triose-phosphate isomerase
(P60174)
Yes 3 1.88
5307 Transaldolase (P37837) 2 3.19
5409 HAnnexin A1 (P04083) 3 1.43
6712 H Lamin A/C (P02545) 3 1.44
7202 HSuperoxide dismutase
Mn (P04179)
2 1.21
7211 HSuperoxide dismutase
Mn (P04179)
3 1.40
7316 Superoxide dismutase
Mn (P04179)
Yes 4 3.15
8212 3-Hydroxyacyl-CoA
dehydrogenase
type II (Q99714)
2 3.27
B. Protein spots showing a lower expression in OAOA vs NoOA
0012 S-100 calcium-binding
protein A1 (P23297)
Yes 1 0.68
0319 Acidic leucine-rich nuclear
phosphoprotein 32 family
member B (Q92688)
Yes 2 0.67
0819 Glucosidase II beta subunit
precursor (P14314)
Yes 5 0.52
1702 HGolgi reassembly stacking
protein 2 (Q9H8Y8)
2 0.60
8404 HAnnexin A2 (P07355) 2 0.31
Fig. 4. Two spots, identiﬁed as vimentin, showed a higher expres-
sion in OAOA samples. Bars represent relative average expression
levels (S.E.M.) of spots 1404 and 1437 in each group. Black:
NoNo, white: NoOA, and shaded: OAOA.
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of 0.06 and 0.08 for spots 1404 and 1437, respectively.
Hence, it may be concluded that both the 1-D and 2-D anal-
yses, point to a higher abundance of low Mw vimentin in
OAOA compared to NoNo and NoOA samples. To further
characterize these bands, a 2-DWestern blot was performed
on two NoNo and two OAOA samples. All samples showed
the same general trend: a decreased Mw between 53 kDa
and 43 kDa was accompanied by a shift toward acidic pI
(Fig. 6). As the N-terminal sequence (78 amino acids) of
native vimentin has a high pI (12.01 as computed by the
pI/Mw tool at www.expasy.org), cleavage of this sequence
will yield a protein with a theoretical pI of 4.71 and Mw of
45 kDa. In contrast, cleavage of the amino acid sequence
at the C-terminus, which yields a protein with a comparable
Mw, resulted in a theoretical pI of 5.20. Both the lower pI
values of lower Mw fragments and the ability to detect the
cleavage products with an antibody directed against a pep-
tide located near the C-terminus, suggest that N-terminus
of vimentin is cleaved. This hypothesis was further conﬁrmed
by MS data. Sequence information about the differentvimentin spots was obtained by MS analysis of three intense
spots at different Mw (Fig. 6). The matched peptides for the
different spots are listed in Table IV. MS data revealed that
none of the matched peptides could be located near the N-
terminus for the spots located at 48 kDa or below, while
high sequence coverage was achieved for the sequence
starting from amino acid 78. Peptides located near the N-
terminus could be identiﬁed in the higher Mw spot. The
combination of these data clearly points to N-terminal vimen-
tin cleavage in OAOA.CONFOCAL MICROSCOPY OF VIMENTIN IN CHONDROCYTES
POINTS TO DISRUPTED VIMENTIN ORGANIZATION IN OAAs it is known that the amino-terminal domain is involved
in the intermediate ﬁlament (IF) assembly23 and in the inter-
action of vimentin with the plasma membrane24, the de-
tected N-terminal cleavage could possibly inﬂuence the
organization of vimentin in chondrocytes. Confocal micros-
copy studies were therefore performed on chondrocyte
samples to test this hypothesis. The images show an al-
tered distribution and organization of vimentin in NoNo
chondrocytes compared to OAOA chondrocytes. Represen-
tative images of each group are shown in Fig. 7. While the
majority of NoNo chondrocytes clearly shows a narrow in-
tense pattern of vimentin expression conﬁned to the cell
membrane (Fig. 8), by contrast OAOA chondrocytes show
a more diffuse distribution of ﬂuorescence within the
cytoplasm.
As described above phosphorylated coﬁlin-1, an enzyme
involved in actin ﬁlament organization, was differentially ex-
pressed. To further elucidate the possible role of this en-
zyme in chondrocyte biology, actin ﬁlaments were stained
using phalloidin-TRITC. Analysis of F-actin stained images
Fig. 5. 1-D Western blot analysis of the soluble fraction of 12 samples (from the left to the right: four NoNo samples, four NoOA samples and
four OAOA samples). (A) Equal amounts of soluble fractions of chondrocytes were loaded on 10% SDS-PAGE and immunoblotted. Immuno-
blotting was performed using monoclonal anti-vimentin (clone V9), where NoNo and NoOA samples show a more intense band at the native
Mw of vimentin (upper box), three OAOA samples show a more intense band near 43 kDa (lower box). (B) and (C) Results of densitometric
analysis. Bars represent relative average density (S.E.M.) of bands per group. Black: NoNo, white: NoOA, and shaded: OAOA.
169Osteoarthritis and Cartilage Vol. 16, No. 2did not reveal clear differences in F-actin organization be-
tween the sample groups.Discussion
The goal of our study was to identify novel molecular
mechanisms or proteins, participating and resulting in carti-
lage breakdown during the pathogenesis of OA. Therefore,
we compared the protein expression patterns of chondro-
cytes obtained from intact cartilage (NoNo), from the visual
intact zones (NoOA) and degenerated zones (OAOA) of OA
cartilage. Chondrocytes were cultured in alginate for 10
days. This culture system allows to selectively isolate the
chondrocytes with their CAM from the interterritorial matrix.
In alginate hydrogel, chondrocytes maintain their original
phenotype and synthesize cartilage-speciﬁc matrix
components25.
Interestingly, the NoOA group shows a different expres-
sion pattern for a substantial number of proteins inFig. 6. 2-D Western blot of the soluble fraction of OAOA sample.
Thirty micrograms of total protein was loaded on 4e7 IPG strip,
transferred to 10% SDS-PAGE. Proteins were transferred to a nitro-
cellulose membrane and vimentin was detected using monoclonal
anti-vimentin (clone V9). 1, 2 and 3 indicate the protein spots that
were excised from a gel, run in parallel to the gels used for Western
blotting.comparison to the NoNo group (see Table I), despite the
fact that the chondrocytes are in both cases isolated from
visually intact cartilage. These data conﬁrm the hypothesis
that chondrocytes undergo phenotypic alterations even be-
fore the development of visible cartilage damage26.
Phenomena such as metabolic activation of OA chondro-
cytes in an attempt to repair cartilage breakdown27, oxidative
stress28 and apoptotic processes29 have previously been re-
ported in the pathogenesis of OA. These phenomena are re-
ﬂected in our analysis by the identiﬁcation of proteins
involved in these biological processes. Proteins involved in
pentose-phosphate pathway (transaldolase and 6-phospho-
gluconolactonase), glycolysis (alpha-enolase and triose-
phosphate isomerase) and oxidative phosphorylation
[ATP-synthase (a-subunit)] were found to be upregulated
in OA chondrocytes or in OAOA chondrocytes vs NoOA
samples. The identiﬁcation of several proteins involved in
these pathways clearly points to a metabolic activation dur-
ing OA, which is a known phenomenon. Furthermore, an
increased role of oxidative phosphorylation in chondrocyte
function under conditions of cartilage stress and increased
energy demands, as might be associated with OA, has
been suggested by Johnson et al.30
The differential expression of peroxiredoxin 6, an enzyme
able to reduce hydroperoxides, Cu/ZnSOD and MnSOD
illustrates the involvement of oxidative stress in the patho-
genesis of OA. The biological role of Cu/ZnSOD
and MnSOD was previously reported in chondrocytes. In
contrast the identiﬁcation of peroxiredoxin 6, as a novel
differentially expressed protein in OA, further contributes
to the elucidation of oxidative stress pathways in the patho-
genesis of OA.
The role of apoptosis in OA is reﬂected by the identiﬁca-
tion of VDAC-1 and VDAC-2 and Annexin A1, which are
proteins known to be involved in apoptotic processes31e33.
The identiﬁcation of VDAC proteins, which have never been
described in chondrocytes, can shed a new light on apopto-
tic processes in chondrocytes.
The cytoskeletal architecture, which consists of a network
of actin microﬁlaments, microtubules and IFs, plays a signif-
icant role in the physiology of chondrocytes. Furthermore,
the cytoskeleton is important in biomechanics and is
Table IV
Results of the identification of three spots, identified as vimentin by Western blotting, at different Mws. Spots were excised from a gel run in
parallel with the Western blots. Peptides, identified by ESI MS/MS, matched to the theoretical sequence are indicated in italics. The indicated
Mws are apparent Mws, as estimated by extrapolation of Mw markers
Matched peptides vimentin 3 (Mw: 53 kDa)
1 STRSVSSSSY RRMFGGPGTA SRPSSSRSYV TTSTRTYSLG SALRPSTSRS
51 LYASSPGGVY ATRSSAVRLR SSVPGVRLLQ DSVDFSLADA INTEFKNTRT
101 NEKVELQELN DRFANYIDKV RFLEQQNKIL LAELEQLKGQ GKSRLGDLYE
151 EEMRELRRQV DQLTNDKARV EVERDNLAED IMRLREKLQE EMLQREEAEN
201 TLQSFRQDVD NASLARLDLE RKVESLQEEI AFLKKLHEEE IQELQAQIQE
251 QHVQIDVDVS KPDLTAALRD VRQQYESVAA KNLQEAEEWY KSKFADLSEA
301 ANRNNDALRQ AKQESTEYRR QVQSLTCEVD ALKGTNESLE RQMREMEENF
351 AVEAANYQDT IGRLQDEIQN MKEEMARHLR EYQDLLNVKM ALDIEIATYR
401 KLLEGEESRI SLPLPNFSSL NLRETNLDSL PLVDTHSKRT LLIKTVETRD
451 GQVINETSQH HDDLE
Matched peptides vimentin 2 (Mw: 48 kDa)
1 STRSVSSSSY RRMFGGPGTA SRPSSSRSYV TTSTRTYSLG SALRPSTSRS
51 LYASSPGGVY ATRSSAVRLR SSVPGVRLLQ DSVDFSLADA INTEFKNTRT
101 NEKVELQELN DRFANYIDKV RFLEQQNKIL LAELEQLKGQ GKSRLGDLYE
151 EEMRELRRQV DQLTNDKARV EVERDNLAED IMRLREKLQE EMLQREEAEN
201 TLQSFRQDVD NASLARLDLE RKVESLQEEI AFLKKLHEEE IQELQAQIQE
251 QHVQIDVDVS KPDLTAALRD VRQQYESVAA KNLQEAEEWY KSKFADLSEA
301 ANRNNDALRQ AKQESTEYRR QVQSLTCEVD ALKGTNESLE RQMREMEENF
351 AVEAANYQDT IGRLQDEIQN MKEEMARHLR EYQDLLNVKM ALDIEIATYR
401 KLLEGEESRI SLPLPNFSSL NLRETNLDSL PLVDTHSKRT LLIKTVETRD
451 GQVINETSQH HDDLE
Matched peptides vimentin 1 (Mw: 44 kDa)
1 STRSVSSSSY RRMFGGPGTA SRPSSSRSYV TTSTRTYSLG SALRPSTSRS
51 LYASSPGGVY ATRSSAVRLR SSVPGVRLLQ DSVDFSLADA INTEFKNTRT
101 NEKVELQELN DRFANYIDKV RFLEQQNKIL LAELEQLKGQ GKSRLGDLYE
151 EEMRELRRQV DQLTNDKARV EVERDNLAED IMRLREKLQE EMLQREEAEN
201 TLQSFRQDVD NASLARLDLE RKVESLQEEI AFLKKLHEEE IQELQAQIQE
251 QHVQIDVDVS KPDLTAALRD VRQQYESVAA KNLQEAEEWY KSKFADLSEA
301 ANRNNDALRQ AKQESTEYRR QVQSLTCEVD ALKGTNESLE RQMREMEENF
351 AVEAANYQDT IGRLQDEIQN MKEEMARHLR EYQDLLNVKM ALDIEIATYR
401 KLLEGEESRI SLPLPNFSSL NLRETNLDSL PLVDTHSKRT LLIKTVETRD
451 GQVINETSQH HDDLE
170 S. Lambrecht et al.: Proteome analysis of normal and OA chondrocytesinvolved in mechanotransduction signaling pathways34.
Vimentin IFs have been implicated in the mechanical inte-
gration of the cellular space35. In chondrocytes it has been
suggested that the vimentin cytoskeleton could be impli-
cated in mechanotransduction20. 2-DE, MS and Western
blot data reveal a more pronounced N-terminal cleavage
of vimentin in OA. Since the amino-terminal domain of vi-
mentin is involved in IF assembly23 and in interaction of
vimentin with the plasma membrane24, we hypothesized
that this vimentin cleavage would be reﬂected in an altered
vimentin organization in OA chondrocytes compared to
healthy chondrocytes. This is conﬁrmed by immunoﬂuores-
cent labeling of vimentin in chondrocytes: the more diffuse
distribution of the ﬂuorescent signal in OAOA chondrocytes
over the cytoplasm, in contrast to intense ﬂuorescence at the
periphery in NoNo chondrocytes, probably reﬂects a distur-
bance in vimentin IF organization and/or a diminished inter-
action of vimentin with the plasma membrane. Taken
together, the combination of spot analysis data, 1-D and
2-D Western blotting, high sequence coverage MS data
and confocal microscopy images points indisputably to a dis-
turbed vimentin organization in OAOA chondrocytes.
Trickey et al.36 demonstrated the possible involvement of
vimentin IFs in the visco-elastic properties of human articu-
lar chondrocytes. Moreover, it has recently been shown that
disassembly of the vimentin cytoskeleton, induced by acryl-
amide, disrupts chondrocyte homeostasis37. In conse-
quence, the observed vimentin distortion probably plays
a role in the pathogenesis of OA.Vimentin cleavage is a process which is described during
apoptosis38,39. Caspase-3 and caspase-8 are reported to be
the proteases involved in apoptosis-related vimentin cleav-
age40. As a higher caspase-3 expression in OA chondro-
cytes is documented29, this enzyme is a candidate
mediator for vimentin cleavage inOA. Nevertheless, the frag-
ments, representing the most intense spots near 44 kDa and
48 kDa, were investigated by MS and contained the known
cleavage site of caspase-3 and caspase-7 (AA 85) and cas-
pase-6 and caspase-8 (AA 259)40,41. This observation
makes caspase-3 cleavage very unlikely. In addition, vimen-
tin cleavage seems to be a phenomenon taking place in the
basal metabolism of chondrocytes, since cleavage products
were also detected in healthy samples. These ﬁndings allow
us to suggest that caspase-mediated apoptotic processes
are probably not involved in the observed vimentin cleavage.
The primary cause of vimentin distortions remains un-
clear. It could be hypothesized that excessive mechanical
load will induce an altered vimentin organization, making vi-
mentin more susceptible to proteases. This hypothesis is
supported by the suggestion of Durrant et al.42 that chon-
drocytes modify their vimentin cytoskeleton in response to
changing mechanical conditions. Alternatively, the ob-
served vimentin alterations could be induced by imbalances
in the autocrine and paracrine anabolic and catabolic path-
ways associated with OA. In OA chondrocytes the catabolic
pathways override the anabolic pathways26, which may re-
sult in OA-associated vimentin breakdown, possibly via
downstream regulation of proteases or chaperone proteins.
Fig. 7. Representative confocal microscopy images of NoNo (upper panel), NoOA (middle panel) and OAOA chondrocytes (lower panel).
Chondrocytes were immunostained for vimentin (green), F-actin (red) and the nucleus (blue), shown as individual channels and in superpo-
sition from the left to the right. Scale bar indicates 5 mm. Green panel (vimentin-staining): the majority of NoNo chondrocytes clearly shows
a narrow zone of ﬂuorescence, in contrast to the spread ﬂuorescence of OAOA chondrocytes. Red panel (F-actin staining): no clear differ-
ences in F-actin staining could be detected between the sample groups. All sample groups show a ﬂuorescence signal distributed over
the cytoplasm. Blue panel: nuclear DAPI stain. Right panel: superimposition of the three images.
Fig. 8. Percentage of chondrocytes showing a narrow intense zone
of ﬂuorescence at the periphery of the cytoplasm (expressed as
meanSD). Cells were incubated with monoclonal anti-vimentin,
followed by the appropriate secondary antibody, labelled in Alexa
Fluor 488. Black: NoNo, white: NoOA, and shaded: OAOA.
171Osteoarthritis and Cartilage Vol. 16, No. 2In conclusion, this study conﬁrmed the metabolic activa-
tion of chondrocytes isolated from OA cartilage and
clearly demonstrated vimentin cytoskeleton disruption in
OA-affected chondrocytes. These observations may shed
new light on the pathogenesis of OA. Whether primary pro-
cesses, involved in vimentin cleavage and cytoskeleton
breakdown, are based on mechanical phenomena, on met-
abolic imbalances or on a combination of both will need fur-
ther research.Acknowledgements
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